Finance

Beta
Lists
ONWD:EBR
Onward Medical NV
€2.83
-1.39%
(-0.040) 1D
Jun 5, 5:35:20 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ONWD...
Open
€2.87
High
€2.90
Low
€2.81
Mkt. cap
196.77M
Avg. vol.
189.38K
Volume
120.79K
52-wk high
€5.77
52-wk low
€2.41
EPS
-€0.90
No. of employees
137
Open
€2.87
High
€2.90
Low
€2.81
Mkt. cap
196.77M
Avg. vol.
189.38K
Volume
120.79K
52-wk high
€5.77
52-wk low
€2.41
EPS
-€0.90
No. of employees
137
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to ONWD in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for ONWD in the last 3 months.
Highest
Current €2.83
€9.70 (+242.76%)
Average
€9.70 (+242.76%)
Lowest
€9.70 (+242.76%)
News stories
From sources across the web
About Onward Medical NV
CEO-
Employees137
Founded2014
Headquarters-
SectorMedical device
Websiteonwd.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
592.50K
592.50K
2.11M
2.11M
Cost of goods sold
3.02M
3.02M
-2.50M
-2.50M
Cost of revenue
3.02M
3.02M
-2.50M
-2.50M
Research and development expenses
1.53M
1.53M
7.50M
7.50M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.04M
6.04M
7.57M
7.57M
Operating expense
7.56M
7.56M
15.07M
15.07M
Total operating expenses
10.58M
10.58M
12.57M
12.57M
Operating income
-9.99M
-9.99M
-10.46M
-10.46M
Other non operating income
-
-
-15.00K
-15.00K
EBT including unusual items
-10.50M
-10.50M
-10.24M
-10.24M
EBT excluding unusual items
-10.50M
-10.50M
-10.24M
-10.24M
Income tax expense
90.00K
90.00K
65.50K
65.50K
Effective tax rate
-0.86%
-0.86%
-0.64%
-0.64%
Other operating expenses
-
-
-
-
Net income
-10.59M
-10.59M
-10.30M
-10.30M
Net profit margin
-1,787.17%
-1,787.17%
-487.33%
-487.33%
Earnings per share
-
-
-
-
Interest and investment income
-
-
290.00K
290.00K
Interest expense
-512.50K
-512.50K
-580.00K
-580.00K
Net interest expenses
-512.50K
-512.50K
-290.00K
-290.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.75M
-9.75M
-10.44M
-10.44M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more